Fezolinetant Clinical Trials
5 recruitingDrug
Phase 23Phase 32
Showing 1–5 of 5 trials
Recruiting
Phase 2
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Yale University92 enrolled2 locationsNCT06917313
Recruiting
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical Practice
Hot Flashes
Astellas Pharma Europe Ltd.238 enrolled2 locationsNCT07602530
Recruiting
Phase 2Phase 3
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
MenopauseMenopause Related ConditionsCardiovascular+1 more
University of Colorado, Denver200 enrolled1 locationNCT06975111
Recruiting
Phase 3
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Hot Flashes
Astellas Pharma Global Development, Inc.540 enrolled117 locationsNCT06440967
Recruiting
Phase 2
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
Androgen Deprivation TherapyProstate CA
University of Vermont32 enrolled1 locationNCT06972875